NEW YORK, May 12 (GenomeWeb News) - Bruker Biosciences CEO Frank Laukien bought more than $666,000 worth of his company's stock since Tuesday, sending the shares up 6.7 percent to $3.83 in mid-afternoon trading today.
According to Insidercow.com, which tracks insider trading at public companies, Laukien bought 176,365 shares at prices between $3.60 and $3.80 per share for a total cost of $666,105.30.